SCHEMBL30987637

SCHEMBL30987637

COC(=O)c1cc(-c2cnc(C)s2)ccc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 3/20 0.40
▸ DYRK1A Q13627 3/20 0.40
▸ WNT1 P04628 2/20 0.40
▸ P2RX7 Q99572 1/20 0.39
▸ AOC3 Q16853 2/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ CASP3 P42574 1/20 0.39
▸ SENP8 Q96LD8 1/20 0.39
▸ SENP7 Q9BQF6 1/20 0.39
▸ SENP6 Q9GZR1 1/20 0.39
▸ CTSK P43235 2/20 0.39
▸ CTSC P53634 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ IKBKB O14920 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27272866 1.00 GSK3B (0.40) GSK3BDYRK1AWNT1P2RX7AOC3
SCHEMBL30987780 0.90 CTSK (0.43) GSK3BDYRK1AWNT1AOC3NPC1
SCHEMBL27272844 0.90 CTSK (0.43) GSK3BDYRK1AWNT1AOC3NPC1
SCHEMBL30987741 0.85 HCAR2 (0.42) GSK3BDYRK1AWNT1P2RX7AOC3
SCHEMBL27272895 0.85 HCAR2 (0.42) GSK3BDYRK1AWNT1P2RX7AOC3
SCHEMBL21873453 0.77 MAPT (0.51) AOC3NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL30987626 0.77 RARB (0.45) AOC3CTSKCTSCPOLQ
SCHEMBL27272881 0.77 RARB (0.45) AOC3CTSKCTSCPOLQ
SCHEMBL2408026 0.77 AOC3 (0.45) GSK3BDYRK1AWNT1AOC3RAB9A
SCHEMBL30987703 0.75 ABL1 (0.44) RAB9AKDM4EALDH1A1L3MBTL1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4676929-A1 PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 Dark Blue Therapeutics Ltd (GB) 2026-01-14 — — EP disclosed
EP-4638447-A1 IMIDAZO[1,2-A]PYRIDINE AND IMIDAZO[1,2-A]PYRAZINE DERIVATIVES AS MLLT1 AND MLLT3 INHIBITORS Dark Blue Therapeutics Ltd (GB) 2025-10-29 — — EP disclosed
WO-2024188906-A1 PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 DARK BLUE THERAPEUTICS LTD (GB) 2024-09-19 — — WO disclosed
WO-2024133560-A1 IMIDAZO[1,2-A]PYRIDINE AND IMIDAZO[1,2-A]PYRAZINE DERIVATIVES AS MLLT1 AND MLLT3 INHIBITORS DARK BLUE THERAPEUTICS LTD (GB) 2024-06-27 — — WO disclosed
Send feedback